Position in SLS
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$0
+$0 QoQ
Shares Held
0
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2021
4 quarters on record
Derivatives in SLS
reported options exposure · as of Jun 30, 2026CallValue
$6,273,000
CallShares
425,000
PutValue
$369,000
PutShares
25,000
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Jun 30, 2026NOMURA HOLDINGS INC holds $218,808,046 across 46 Biotechnology names.
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | IONS |
Ionis Pharmaceuticals Inc
|
402,192 | $31,889,803 | |
| 2 | BBIO |
BridgeBio Pharma, Inc.
|
327,475 | $24,390,338 | |
| 3 | LGND |
Ligand Pharmaceuticals Inc
|
61,938 | $19,577,982 | |
| 4 | AUPH |
Aurinia Pharmaceuticals Inc.
|
978,602 | $16,606,875 | |
| 5 | HRMY |
Harmony Biosciences Holdings, Inc.
|
417,932 | $15,216,904 | |
| 6 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
29,198 | $14,503,522 | |
| 7 | OABI |
OmniAb, Inc.
|
5,028,160 | $12,369,273 | |
| 8 | REGN |
Regeneron Pharmaceuticals, Inc.
|
14,320 | $8,929,092 |
All Filings in SLS
Export CSV
5 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $369,000 | 25,000 | Put | Defined | 2026-08-14 | |
| 2026-06-30 | $6,273,000 | 425,000 | Call | Defined | 2026-08-14 | |
| 2026-03-31 | $1,847,241 | 436,700 | Call | Defined | 2026-05-15 | |
| 2025-12-31 | $1,974,349 | 523,700 | Call | Defined | 2026-02-17 | |
| 2021-03-31 | $1,123,010 | 131,500 | Shares | Sole | 2021-05-17 | |
| No filing history on record for this holder in this stock. | ||||||